文献速递皮肤感染

Delta与Omicron波期间SARS-CoV-2感染的皮肤表现在348691名英国ZOE COVID研究应用用户中的特征

Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app.
PubMed 文献 · Br J Dermatol · 2022-10-10

这项回顾性研究基于348691名英国ZOE COVID研究应用用户的自报数据,按年龄、性别、疫苗接种状态和自报湿疹诊断在Delta与Omicron波之间1:1匹配,评估五种皮肤表现对SARS-CoV-2感染的诊断价值、频率和持续时间。结果显示任何皮肤表现与SARS-CoV-2检测阳性显著相关,Delta波的诊断价值高于Omicron波(比值比2.29,95%置信区间2.22-2.36,P<0.001;比值比1.29,95%置信区间1.26-1.33,P<0.001)。皮肤表现Delta波较Omicron波更常见(17.6% vs 11.4%)且持续时间更长,接种与未接种疫苗用户出现皮肤表现的比值相似,仅灼热性皮疹在接种用户中比值较低。

要点

  • 任何皮肤表现与SARS-CoV-2检测阳性显著相关,Delta波诊断价值高于Omicron波。
  • 皮肤表现Delta波较Omicron波更常见(17.6% vs 11.4%)且持续时间更长。
  • 两波期间皮肤症状多与其他常见症状聚集出现,仅<2%用户作为首发或唯一临床征象。

核心结论

  • 皮肤表现对SARS-CoV-2感染有预测价值,其频率和持续时间随变异株变化。
  • 作者主张将皮肤表现纳入临床相关COVID-19症状列表,并建议监测皮肤表现可能有助于识别新变异株。

研究设计与样本

  • 回顾性研究,使用348691名英国ZOE COVID研究应用用户的自报数据。
  • 按年龄、性别、疫苗接种状态和自报湿疹诊断在Delta与Omicron波之间1:1匹配。
  • 评估五种皮肤表现(肢端、灼热性、红斑丘疹性和荨麻疹性皮疹及异常脱发)的诊断价值、频率和持续时间。
  • 还探究疫苗接种对症状频率的影响。

主要发现

  • 任何皮肤表现与SARS-CoV-2检测阳性显著相关,Delta波比值比2.29(95%置信区间2.22-2.36,P<0.001),Omicron波比值比1.29(95%置信区间1.26-1.33,P<0.001)。
  • 皮肤表现Delta波较Omicron波更常见(17.6% vs 11.4%),且持续时间更长。
  • 两波期间皮肤症状多与其他常见症状聚集出现,仅<2%用户作为首发或唯一临床征象。
  • 接种与未接种疫苗用户出现皮肤表现的比值相似,仅灼热性皮疹在接种用户中比值较低。

临床怎么用

  • 作者主张将皮肤表现纳入临床相关COVID-19症状列表。
  • 作者建议监测皮肤表现可能有助于识别新变异株。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Symptoms of SARS-CoV-2 infection have differed during the different waves of the pandemic but little is known about how cutaneous manifestations have changed. OBJECTIVES: To investigate the diagnostic value, frequency and duration of cutaneous manifestations of SARS-CoV-2 infection and to explore their variations between the Delta and Omicron waves of the pandemic. METHODS: In this retrospective study, we used self-reported data from 348 691 UK users of the ZOE COVID Study app, matched 1 : 1 for age, sex, vaccination status and self-reported eczema diagnosis between the Delta and Omicron waves, to assess the diagnostic value, frequency and duration of five cutaneous manifestations of SARS-CoV-2 infection (acral, burning, erythematopapular and urticarial rash, and unusual hair loss), and how these changed between waves. We also investigated whether vaccination had any effect on symptom frequency. RESULTS: We show a significant association between any cutaneous manifestations and a positive SARS-CoV-2 test result, with a diagnostic value higher in the Delta compared with the Omicron wave (odds ratio 2·29, 95% confidence interval 2·22-2·36, P < 0·001; and odds ratio 1·29, 95% confidence interval 1·26-1·33, P < 0·001, respectively). Cutaneous manifestations were also more common with Delta vs. Omicron (17·6% vs. 11·4%, respectively) and had a longer duration. During both waves, cutaneous symptoms clustered with other frequent symptoms and rarely (in < 2% of the users) as first or only clinical sign of SARS-CoV-2 infection. Finally, we observed that vaccinated and unvaccinated users showed similar odds of presenting with a cutaneous manifestation, apart from burning rash, where the odds were lower in vaccinated users. CONCLUSIONS: Cutaneous manifestations are predictive of SARS-CoV-2 infection, and their frequency and duration have changed with different variants. Therefore, we advocate for their inclusion in the list of clinically relevant COVID-19 symptoms and suggest that their monitoring could help identify new variants. What is already known about this topic? Several studies during the wildtype COVID-19 wave reported that patients presented with common skin-related symptoms. It has been observed that COVID-19 symptoms differ among variants. No study has focused on how skin-related symptoms have changed across different variants. What does this study add? We showed, in a community-based retrospective study including over 348 000 individuals, that the presence of cutaneous symptoms is predictive of SARS-CoV-2 infection during the Delta and Omicron waves and that this diagnostic value, along with symptom frequency and duration, differs between variants. We showed that infected vaccinated and unvaccinated individuals reported similar skin-related symptoms during the Delta and Omicron waves, with only burning rashes being less common after vaccination.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Visconti A, Murray B, Rossi N, et al. Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app. Br J Dermatol. 2022. PMID: 35869671. doi:10.1111/bjd.21784

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。